The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) ...
LifeStance Health reports GLP-1 medications, known for weight loss, may also enhance mental health by improving mood, ...
SELECT was a large study focused on obesity and cardiovascular disease in people without type 2 diabetes, but it included ...
Researchers developed a model using routine clinical data to identify optimal glucose-lowering therapies for patients with type 2 diabetes (T2D). Individuals receiving model-predicted optimal therapy ...
A groundbreaking development in diabetes treatment reveals that SGLT-2 inhibitors significantly reduce dementia risk among type 2 diabetes patients. Recent research demonstrates these medications ...
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh ...
New research shows that cardiovascular protection from GLP-1 receptor agonists such as semaglutide and tirzepatide diminishes ...
Analysis of over 750,000 pregnancies reveals that GLP-1 weight loss drugs are safe in early pregnancy, but pose risks when used for diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results